Article
Prognostic Value of RUNX1 Mutations in AML: A Meta-Analysis
26 Feb 2018
Abstract excerpt
The RUNX1 (AML1) gene is a relatively infrequent mutational target in cases of acute myeloid leukemia (AML). Previous work indicated that RUNX1 mutations can have pathological and prognostic implications. To evaluate prognostic value, we conducted a meta-analysis of 4 previous published works with data for survival according to RUNX1 mutation status. Pooled hazard ratios for overall survival and disease-free...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
